Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
DHEA + Acolbifene for Hot Flushes
NCT01452373Phase 3Completed
- Sponsor
- Endoceutics
- Start
- Oct 2011
- Primary completion
- Dec 2012
- Modality
- Allosteric Modulators, Orthosteric Ligands
- Countries
- 1
01
Overview
Phase 3, randomised, double-blind trial in vasomotor symptoms comparing Control (placebo) with DHEA + Acolbifene (2 arms). Primary endpoints: Change from baseline to week 12 in frequency of moderate to severe hot flushes and Change from baseline to week 12 in severity of moderate to severe hot flushes. Started Oct 2011; status: completed.
02
Drugs
acolbifeneprasterone
03
Conditions
vasomotor symptoms
Beyond the preview
Go deeper on NCT01452373.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on NCT01452373.